Head-to-head · Value Score
bmiMD vs FormBlends
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, FormBlends a 69. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameFormBlends
#257 · Grade C · Watch List
Est. first month
From $99/mo (compounded)
Save ~93% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 69 — an est. $99/mo first month, with no teaser step-up baked in. FormBlends isn't out of it: Shoppers wanting a low compounded-semaglutide entry price with lots of on-site education.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | FormBlends |
|---|---|---|
| Value Score | 89 (A) | 69 (C) |
| Est. first month | $99/mo | From $99/mo (compounded) |
| Save vs brand-name | ~93% | ~93% |
| Semaglutide | $99/mo | From $99/mo (compounded) |
| Tirzepatide | $139/mo | From $349/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
FormBlends
FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…
Why it's a deal
- Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
- Physician-supervised program with 24/7 care-team access and free shipping over $150
- Extensive free educational content, guides and provider comparisons on-site
The fine print
- Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
- $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
- State availability and LegitScript status not published; pharmacy is its own FormScripts brand
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to FormBlends.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.